NEW YORK, NY, Inductive Bio, a technology company democratizing artificial intelligence (AI) models to transform small molecule drug discovery, announced that it has raised $25M in Series A.
Inductive Bio, a technology company democratizing artificial intelligence (AI) models to transform small molecule drug discovery, announced that it has raised $25M in Series A financing led by Obvious Ventures with participation from Andreessen Horowitz (a16z) Bio + Health, Lux Capital, S32, Character, and Amino Collective, alongside angel investors including Oren Etzioni, Jeff Hammerbacher, Malay Gandhi, and Jakob Uszkoreit.
(c) by Massinvestor, Inc. For contact info, please check out our
about page.
